Caricamento...
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
The use of intracellular antibodies as templates to derive surrogate compounds is an important objective because intracellular antibodies can be employed initially for target validation in pre-clinical assays and subsequently employed in compound library screens. LMO2 is a T cell oncogenic protein a...
Salvato in:
| Pubblicato in: | J Immunol Methods |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208243/ https://ncbi.nlm.nih.gov/pubmed/33794223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2021.113051 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|